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function of cardiac tissue made from human pluripotent stem cell-
derived CMs by using ECM patterns inspired by the embryonic heart.
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The use of temporary scaffolds in Advanced Therapies and in
particular of Tissue Engineering is one of the key issues to regenerate
tissue defects. The scaffolds should be speciﬁcally designed to create
environments that promote tissue development and not merely to
support the maintenance of communities of cells. Many biomaterials
have been proposed to produce scaffolds aiming the regeneration of a
wealth of human tissues. We have a particular interest in developing
systems based in nanoﬁbrous biodegradable polymers1,2. Those
demanding applications require a combination of mechanical proper-
ties, processability, cell-friendly surfaces and tunable biodegradability
that need to be tailored for the speciﬁc application envisioned. In our
approach, we combine the temporary scaffolds populated with thera-
peutically relevant communities of cells to generate a hybrid implant.
We are exploring the use of adult MSCs3, namely obtained from the
bone marrow for the development of autologous-based therapies. We
also develop strategies based in extra-embryonic tissues, such as am-
niotic ﬂuid (AF) and the perivascular region of the umbilical cord4
(Wharton’s Jelly, WJ). Those tissues offer many advantages over both
embryonic and other adult stem cell sources. The comparatively large
volume of tissue and ease of physical manipulation facilitates the
isolation of larger numbers of stem cells. Fetal stem cells seem having
more pronounced immunomodulatory properties than adult MSCs.
This allogeneic escape mechanism may be of therapeutic value, be-
cause the transplantation of readily available allogeneic human MSCs
would be preferable as opposed to the required expansion stage (in-
volving both time and logistic effort) of autologous cells.
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The use of stem cells is a promising therapeutic approach for the
substantial challenge to regenerate cartilage. Considering the two
prerequisites, namely the use of a 3D system to enable the chondro-
genic differentiation and growth factors to avoid dedifferentiation, the
diffusion efﬁciency of essential biomolecules is an intrinsic issue. We
already proposed a liquiﬁed bioencapsulation system containing mi-
croparticles as cell adhesion sites1. Here, we intend to use the opti-
mized system towards chondrogenic differentiation by encapsulating
stem cells and collagen II-TGF-b3 coated PLLA microparticles. As a
proof-of-concept, magnetite-nanoparticles were incorporated into the
multilayered-membrane. This can be a great advantage after implan-
tation procedures to ﬁxate the capsules in situ with the help of an
external magnetic patch and for the follow-up through imaging. Re-
sults showed that the production of glycosaminoglycans and the ex-
pression of cartilage-relevant markers (collagen II, Sox9, aggrecan,
and COMP) increased up to 28 days, while hypertrophic (collagen X)
and ﬁbrotic (collagen I) markers were downregulated. The presence of
nanoﬁbers in the newly deposited ECMwas visualized by SEM,which
resembles the collagen ﬁbrils of native cartilage. The presence of the
major constituent of cartilage, collagen II, was detected by immuno-
cytochemistry. Safranin-O and alcian blue stainings revealed a baso-
philic ECM deposition, which is characteristic of neocartilage. These
ﬁndings suggest that the proposed system may provide a suitable self-
governing environment for chondrogenic differentiation.
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A critical criterion for the clinical success of hydrogel scaffolds is
their ability to promote rapid and stable neovascularization upon im-
plantation prior to material degradation. Previous studies have shown
that controlled and sustained growth factor presentation in hydrogels
enhances scaffold neovascularization. A promising alternative to growth
factors are synthetic growth factor mimetic peptide sequences designed
to interact with the speciﬁc receptors growth factors use to regulate
neovascularization pathways while possessing lower susceptibility to
degradation in vivo. A peptide mimetic sequence based on vascular
endothelial growth factor (VEGF), QK, has been previously developed
which activates the signaling pathway involved in VEGF-mediated
neovascularization. Recent 3D cell culture studies indicate that contin-
uous replenishment of solubleQK signiﬁcantly enhances endothelial cell
outgrowth compared to immobilized QK presentation. We have devel-
oped a hydrogel-based nanocomposite platform that allows for sustained
release of the QK peptide within protease-sensitive hydrogel scaffolds.
Speciﬁcally, QK peptide was loaded within poly(ethylene glycol) (PEG)
hydrogel nanoparticles (NPs) which were subsequently encapsulated
within protease-sensitive PEG scaffolds. QK loaded NPs were formed
using inverse phase miniemulsion polymerization and allowed peptide
release up to 63 days. Alterations in QK release from hydrogel NPs was
achieved through increases in PEG crosslinker macromer size or by
rendering the macromer hydrolytically degradable. Nanoparticle track-
ing analysis revealed an average particle diameter of 155.0–77.9 nm;
zeta potential was -29.6–5.84 mV; and NP swelling ratio was
17.2–5.0. Current studies are investigating the role of variations in QK
release kinetics on scaffold neovascularization in vitro.
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Problem: Metastasis contributes to over 90% of cancer-related
deaths. For metastasis to occur, cancer cells detach from the primary
tumor and invade the bloodstream as circulating tumor cells (CTCs).
Adhesive interactions between selectins on the blood vessel wall and
selectin ligands on the CTC surface facilitate metastatic progression.
Objective: Here, we describe a novel approach to functionalize
human and murine leukocytes with tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL), along with E-selectin (ES), to
capture and induce cancer cell apoptosis both in vitro in human blood
and in vivo in mouse circulation.
Methodology: ES/TRAIL liposomes and cancer cells suspended
in human blood were subjected to shear ﬂow, and assessed for via-
bility using ﬂow cytometry (FC). For in vivo studies, mice were
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